Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Climb Bio, Inc.
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
April 01, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
ABOS
ASX:IMU
CLYM
LENZ
Climb Bio to Present at the 24th Annual Needham Virtual Healthcare Conference
March 27, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Updates
March 25, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio to Present at Upcoming Investor Conferences
February 25, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer
February 24, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 04, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy
January 09, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio to be Added to the Nasdaq Biotechnology Index
December 19, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights
November 12, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
November 11, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio to Present at Upcoming Investor Conferences
October 31, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event
October 15, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024
October 11, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19
October 04, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio to Host Virtual Investor Event on October 15, 2024
October 03, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.